Skip to content
User

Ole Andreas Halvorsen

Viking Global Investors

Ole Andreas Halvorsen HCA Healthcare, Inc stake

total: 670

Viking Global Investors HCA trades

Total transactions:
23
New positions:
5
Sold out:
5
Added:
7
Reduced:
6
Held since:
2023 Q4
Held for:
10 quarters
Latest activity:
2026 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any HCA Healthcare, Inc (HCA) shares. To date, the estimated cost basis is nearly $327.95 for "buy" trades and estimated average "sell" price is $448.56. Viking Global Investors first purchased HCA in 2013 Q3, initially acquiring about 2.78M shares. Ole Andreas Halvorsen later completely sold out the position and invested in HCA Healthcare, Inc again in 2023 Q4. Since the initial investment in HCA Healthcare, Inc (HCA), Viking Global Investors has made 22 more transactions.

When did Ole Andreas Halvorsen sell HCA Healthcare, Inc (HCA)?

Ole Andreas Halvorsen sold off the entire HCA Healthcare, Inc (HCA) position in 2026 Q2.

When did Ole Andreas Halvorsen buy HCA Healthcare, Inc (HCA)?

Ole Andreas Halvorsen first invested in HCA Healthcare, Inc (HCA) in 2013 Q3 at the reported quarter-end price of $42.75 per share.

What's the cost basis of Viking Global Investors's HCA stake?

The estimated cost basis for HCA Healthcare, Inc (HCA) stake is around $327.95 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$327.95
Weighted AVG sell price:
$448.56

Ole Andreas Halvorsen's historical trades in HCA Healthcare, Inc

23 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q2
0.00%
0
$473.24
-100% (-1,075,133)
-1.42%
2026 Q1
1.42%
1,075,133
$473.24
$508,795,941
+7.60% (+75,953)
+0.1%
2025 Q4
1.24%
999,180
$466.86
$466,477,175
-27.63% (-381,403)
-0.46%
2025 Q3
1.53%
1,380,583
$426.20
$588,404,475
-26.26% (-491,550)
-0.61%
2025 Q2
2.07%
1,872,133
$383.10
$717,214,152
+58.47% (+690,773)
+0.77%
2025 Q1
1.30%
1,181,360
$345.55
$408,218,948
+6.41% (+71,130)
+0.08%
2024 Q4
1.08%
1,110,230
$300.15
$333,235,535
+59.05% (+412,200)
+0.4%
2024 Q3
1.03%
698,030
$406.43
$283,700,333
+6.71% (+43,863)
+0.06%
2024 Q2
0.81%
654,167
$321.28
$210,170,774
+23.57% (+124,766)
+0.15%
2024 Q1
0.66%
529,401
$333.53
$176,571,116
-27.00% (-195,815)
-0.24%
2023 Q4
0.72%
$270.68
new
2021 Q2
0.00%
$188.34
-100% (-1,498,742)
2021 Q1
0.84%
$188.34
-14.27% (-249,452)
2020 Q4
0.79%
$164.46
new
2016 Q3
0.00%
$77.01
-100% (-1,089,482)
2016 Q2
0.36%
$77.01
new
2015 Q2
0.00%
$75.23
-100% (-1,016,617)
2015 Q1
0.30%
$75.23
-73.74% (-2,854,037)
2014 Q4
1.30%
$73.39
+115.66% (+2,075,874)
2014 Q3
0.51%
$70.52
new
2014 Q1
0.00%
$47.71
-100% (-2,654,617)
2013 Q4
0.59%
$47.71
-4.62% (-128,714)
2013 Q3
0.66%
$42.75
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.